HAG
HighPoint Advisor Group’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $256K | Buy |
+5,263
| New | +$256K | 0.01% | 569 |
|
|
2025
Q1 | – | Sell |
-5,091
| Closed | -$202K | – | 672 |
|
|
2024
Q4 | $202K | Buy |
5,091
+92
| +2% | +$3.65K | 0.01% | 635 |
|
|
2024
Q3 | $254K | Buy |
4,999
+438
| +10% | +$22.2K | 0.01% | 550 |
|
|
2024
Q2 | $257K | Sell |
4,561
-14
| -0.3% | -$789 | 0.02% | 517 |
|
|
2024
Q1 | $255K | Buy |
4,575
+261
| +6% | +$14.5K | 0.02% | 510 |
|
|
2023
Q4 | $307K | Buy |
+4,314
| New | +$307K | 0.02% | 466 |
|
|
2022
Q2 | $278K | Buy |
+3,826
| New | +$278K | 0.03% | 408 |
|
|
2021
Q3 | $922K | Buy |
8,239
+237
| +3% | +$26.5K | 0.09% | 187 |
|
|
2021
Q2 | $1.3M | Sell |
8,002
-143
| -2% | -$23.1K | 0.13% | 132 |
|
|
2021
Q1 | $943K | Buy |
8,145
+2,007
| +33% | +$232K | 0.11% | 152 |
|
|
2020
Q4 | $1.03M | Buy |
6,138
+248
| +4% | +$41.5K | 0.13% | 139 |
|
|
2020
Q3 | $609K | Buy |
5,890
+590
| +11% | +$61K | 0.11% | 154 |
|
|
2020
Q2 | $416K | Buy |
5,300
+150
| +3% | +$11.8K | 0.09% | 190 |
|
|
2020
Q1 | $278K | Buy |
+5,150
| New | +$278K | 0.07% | 224 |
|
|
2019
Q4 | – | Sell |
-3,400
| Closed | -$171K | – | 393 |
|
|
2019
Q3 | $171K | Buy |
3,400
+750
| +28% | +$37.7K | 0.04% | 339 |
|
|
2019
Q2 | $130K | Buy |
+2,650
| New | +$130K | 0.03% | 392 |
|